CS logo
small CS logo
Tampa General Hospital

Tampa, Florida, United States
Medical center in Tampa, Florida
1 Tampa General Cir, Tampa, FL 33606
1,041 Beds

About Tampa General Hospital


Tampa General Hospital is a 1,041-bed non-profit, tertiary, research and academic medical center located on Davis Island in Tampa, Florida, servicing western Florida and the greater Tampa Bay region. TGH is one of the region's only university-level academic medical centers.
There are 1,041 beds in Tampa General Hospital.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Children's Oncology Group
36
University of South Florida
34
National Cancer Institute (NCI)
18
Abbott Medical Devices
16
Gilead Sciences
9
Boston Scientific Corporation
7
Tampa General Hospital
7
TransMedics
7
Florida Orthopaedic Institute
6
Shire
6
CareDx
5
Total Rows: 100

Clinical Trials at Tampa General Hospital


During the past decade, Tampa General Hospital conducted 154 clinical trials. In the 10-year time frame, 154 clinical trials started and 92 clinical trials were completed, i.e. on average, 59.7% percent of trials that started reached the finish line to date. In the past 5 years, 54 clinical trials started and 45 clinical trials were completed. i.e. 83.3% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years2222262623231313161632321414881010447711111515131317171010Started TrialsCompleted Trails20152016201720182019202020212022010203040
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
OSI-774 (Tarceva) Plus Gemcitabine in Patients With Locally Advanced, Unresectable or Metastatic Pancreatic Cancer.
2001-11-29
2004-01-15
Completed
569
Prevention of Autogenous Vein Graft Failure in Peripheral Artery Bypass Procedures
2001-11-01
2004-11-01
Completed
1,400
A Study to Evaluate the Effects of YM872 on Brain Function and Disability When Administered in Combination With Alteplase (Tissue Plasminogen Activator)
2000-12-01
2003-01-01
Completed
A Study to Evaluate the Effects of ONO-2506 Intravenous Infusion in Patients With Acute Ischemic Stroke
2002-11-01
Terminated
1,320
A Study of TNFerade™ Biologic With 5-FU and Radiation Therapy for First-Line Treatment of Unresectable Locally Advanced Pancreatic Cancer
Completed
Prevention of Vascular Access Graft Failure in Patients With Chronic Renal Failure Requiring Hemodialysis
2004-05-01
Terminated
XL119 Versus 5-Fluorouracil (5-FU) Plus Leucovorin (LV) in Subjects With Advanced Biliary Tumors
2004-09-01
2006-11-01
Terminated
248
A Study of Safety, Tolerability & Efficacy of Certican in de Novo Heart Transplant (Tx) Patients
2004-08-09
2007-01-08
Completed
199

Rows per page:

1–100 of 314

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Tampa General Hospital" #1 sponsor was "Children's Oncology Group" with 36 trials, followed by "University of South Florida" with 34 trials sponsored, "National Cancer Institute (NCI)" with 18 trials sponsored, "Abbott Medical Devices" with 16 trials sponsored and "Gilead Sciences" with 16 trials sponsored. Other sponsors include 196 different institutions and companies that sponsored additional 134 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Tampa General Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 43 trials as a collaborator, "Tampa General Hospital" with 5 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 4 trials as a collaborator, "Thoratec Corporation" with 4 trials as a collaborator and "CTI Clinical Trial and Consulting Services" with 3 trials as a collaborator. Other collaborators include 132 different institutions and companies that were collaborators in the rest 121 trials.
Created with Highcharts 11.1.0Top Leading SponsorsChildren's Oncology Group: 36Children's Oncology Group: 36University of South Florida: 34University of South Florida: 34National CancerInstitute (NCI): 18National CancerInstitute (NCI): 18Abbott Medical Devices: 16Abbott Medical Devices: 16Gilead Sciences: 9Gilead Sciences: 9Boston Scientific Corporation: 7Boston Scientific Corporation: 7Tampa General Hospital: 7Tampa General Hospital: 7TransMedics: 7TransMedics: 7Florida Orthopaedic Institute: 6Florida Orthopaedic Institute: 6Shire: 6Shire: 6

Created with Highcharts 11.1.0Top CollaboratorsNational CancerInstitute (NCI): 43National CancerInstitute (NCI): 43Tampa General Hospital: 5Tampa General Hospital: 5National Institute ofNeurological Disordersand Stroke (NINDS): 4National Institute ofNeurological Disordersand Stroke (NINDS): 4Thoratec Corporation: 4Thoratec Corporation: 4CTI Clinical Trial andConsulting Services: 3CTI Clinical Trial andConsulting Services: 3Gilead Sciences: 3Gilead Sciences: 3Integra LifeSciencesCorporation: 3Integra LifeSciencesCorporation: 3Orthopaedic TraumaAssociation: 3Orthopaedic TraumaAssociation: 3Advanced ClinicalResearch Services, LLC:2Advanced ClinicalResearch Services, LLC:2Biomedical AdvancedResearch andDevelopment Authority:2Biomedical AdvancedResearch andDevelopment Authority:2

Clinical Trials Conditions at Tampa General Hospital


According to Clinical.Site data, the most researched conditions in "Tampa General Hospital" are "Heart Failure" (11 trials), "Burns" (8 trials), "Malignant Solid Neoplasm" (8 trials), "Acute Lymphoblastic Leukemia" (5 trials) and "Acute Myeloid Leukemia" (5 trials). Many other conditions were trialed in "Tampa General Hospital" in a lesser frequency.

Clinical Trials Intervention Types at Tampa General Hospital


Most popular intervention types in "Tampa General Hospital" are "Drug" (139 trials), "Device" (91 trials), "Other" (79 trials), "Procedure" (50 trials) and "Biological" (24 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (35 trials), "Laboratory Biomarker Analysis" (24 trials), "Questionnaire Administration" (18 trials), "Cyclophosphamide" (16 trials) and "Biospecimen Collection" (13 trials). Other intervention names were less common.

Clinical Trials Genders at Tampa General Hospital


The vast majority of trials in "Tampa General Hospital" are 301 trials for "All" genders, 10 trials for "Female" genders and 3 trials for "Male" genders.

Clinical Trials Status at Tampa General Hospital


Currently, there are 105 active trials in "Tampa General Hospital". 3 are not yet recruiting, 58 are recruiting, 41 are Active, not recruiting, and 3 are Enrolling by invitation. In total, there were 142 completed trials in Tampa General Hospital, 4 suspended trials, and 38 terminated clinical trials to date.
Out of the total trials that were conducted in Tampa General Hospital, 9 "Phase 1" clinical trials were conducted, 62 "Phase 2" clinical trials and 80 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 15 trials, and there were also 92 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhaseNot Applicable: 92Not Applicable: 92Phase 3: 80Phase 3: 80Phase 2: 62Phase 2: 62Phase 4: 15Phase 4: 15Phase 1: 9Phase 1: 9

Created with Highcharts 11.1.0Trials StatusCompleted: 142Completed: 142Recruiting: 58Recruiting: 58Active, not recruiting: 41Active, not recruiting: 41Terminated: 38Terminated: 38Unknown status: 20Unknown status: 20Suspended: 4Suspended: 4Withdrawn: 4Withdrawn: 4Enrolling by invitation: 3Enrolling by invitation: 3Not yet recruiting: 3Not yet recruiting: 3No longer available: 1No longer available: 1

Departments of Tampa General Hospital


Tampa General Hospital has several departments that took part in Clinical trials: "Tampa Children's Hospital" - 14 trials, "Tampa General Hospital Cardiac and Lung Transplant Clinic" - 5 trials, "Florida Orthopaedic Institute- Tampa General Hospital" - 3 trials
Departments List
Name
City
Trials